Cargando…

Mindfulness-based intervention improves residual negative symptoms and cognitive impairment in schizophrenia: a randomized controlled follow-up study

BACKGROUND: Residual negative symptoms and cognitive impairment are common for chronic schizophrenia patients. The aim of this study was to investigate the efficacy of a mindfulness-based intervention (MBI) on negative and cognitive symptoms of schizophrenia patients with residual negative symptoms....

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Hui, Zhang, Li, Li, Yuhuan, Zheng, Denise, Du, Lizhao, Xu, Feikang, Xu, Chuchen, Liu, Yan, Shen, Jie, Li, Zezhi, Cui, Donghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009398/ https://www.ncbi.nlm.nih.gov/pubmed/36468948 http://dx.doi.org/10.1017/S0033291721002944

Ejemplares similares

Association Between Metabolic Risk Factors and Cognitive Impairment in Schizophrenia Based on Sex
por: Huang, Hongna, et al.
Publicado: (2023)

Characteristics of theory of mind impairment and its relationship with clinical symptoms and neurocognition in patients with schizophrenia
por: Wu, Ying, et al.
Publicado: (2023)

Neuregulin 3 rs10748842 polymorphism contributes to the effect of body mass index on cognitive impairment in patients with schizophrenia
por: Zhou, Yongjie, et al.
Publicado: (2020)

The Interaction of BDNF and NTRK2 Gene Increases the Susceptibility of Paranoid Schizophrenia
por: Lin, Zheng, et al.
Publicado: (2013)

Sex differences between serum total bilirubin levels and cognition in patients with schizophrenia
por: He, Shen, et al.
Publicado: (2021)

Effects of olanzapine on anhedonia in schizophrenia: mediated by complement factor H
por: Zhang, Yi, et al.
Publicado: (2023)

NEGATIVE SYMPTOMS AND NEGATIVE SCHIZOPHRENIA
por: Chaturvedi, S.K., et al.
Publicado: (1984)

Dispositional Mindfulness and Psychotic Symptoms in Schizophrenia Spectrum Disorders: The Mediating Roles of Rumination and Negative Emotion
por: Lam, Angie Ho Yan, et al.
Publicado: (2022)

Negative symptoms in schizophrenia
por: Mitra, Sayantanava, et al.
Publicado: (2016)

NLRP3 Influences Cognitive Function in Schizophrenia in Han Chinese
por: Liu, Ruimei, et al.
Publicado: (2021)

FOXP2 contributes to the cognitive impairment in chronic patients with schizophrenia
por: Lang, Xiaoe, et al.
Publicado: (2019)

Residual Negative Symptoms Differentiate Cognitive Performance in Clinically Stable Patients with Schizophrenia and Bipolar Disorder
por: Krishnadas, Rajeev, et al.
Publicado: (2014)

Impaired Effort Allocation in Patients with Recent-Onset Schizophrenia and Its Relevance to Negative Symptoms Assessments and Persistent Negative Symptoms
por: Ince Guliyev, Ezgi, et al.
Publicado: (2022)

NEGATIVE SYMPTOMS IN SCHIZOPHRENIA AND DEPRESSION
por: Chaturvedi, S.K., et al.
Publicado: (1985)

Theory of mind deficits partly mediate impaired social decision-making in schizophrenia
por: Yang, Liuqing, et al.
Publicado: (2017)

Inflexible Minds: Impaired Attention Switching in Recent-Onset Schizophrenia
por: Smid, Henderikus G. O. M., et al.
Publicado: (2013)

Theory of Mind in Bipolar Disorder, with Comparison to the Impairments Observed in Schizophrenia
por: Mitchell, Rachel L. C., et al.
Publicado: (2016)

Effect of Virtual Reality on Cognitive Impairment and Clinical Symptoms among Patients with Schizophrenia in the Remission Stage: A Randomized Controlled Trial
por: Li, Shangda, et al.
Publicado: (2022)

Therapeutic effect of qinghuanling on negative symptoms and cognitive function of schizophrenia
por: Zhang, Y., et al.
Publicado: (2021)

Negative and Neutral Valences of Affective Theory of Mind are More Impaired than Positive Valence in Clinically Stable Schizophrenia Patients
por: Charernboon, Thammanard
Publicado: (2020)

Tackling Negative Symptoms of Schizophrenia with Memantine
por: Paraschakis, Antonios
Publicado: (2014)

The Effects of Bupropion on Negative Symptoms in Schizophrenia
por: Yassini, Mojtaba, et al.
Publicado: (2014)

Clozapine: Improvement of Negative Symptoms of Schizophrenia
por: Khan, Afaque H, et al.
Publicado: (2017)

Treating Negative Symptoms in Schizophrenia: an Update
por: Remington, Gary, et al.
Publicado: (2016)

Primary and Secondary Negative Symptoms in Schizophrenia
por: Mosolov, Sergey N., et al.
Publicado: (2022)

MDMA for the Treatment of Negative Symptoms in Schizophrenia
por: Arnovitz, Mitchell D., et al.
Publicado: (2022)

Predictive biomarkers for negative symptoms in schizophrenia
por: Cakici, N., et al.
Publicado: (2021)

Management of cognitive and negative symptoms in schizophrenia
por: Maroney, Megan
Publicado: (2022)

Marker of schizophrenia with enduring negative symptoms
por: Dmitrieva, E., et al.
Publicado: (2022)

Increased plasma leptin as a novel predictor for psychopathological depressive symptoms in chronic schizophrenia
por: Xu, Jinjie, et al.
Publicado: (2018)

Genetic Association of Olanzapine Treatment Response in Han Chinese Schizophrenia Patients
por: Zhou, Wei, et al.
Publicado: (2019)

Impact of negative symptoms on health-related quality of life in schizophrenia
por: Li, Yanhui, et al.
Publicado: (2023)

The efficacy of homestyle rehabilitation on negative symptoms in chronic schizophrenia: A randomized controlled trial
por: Chai, Jiabao, et al.
Publicado: (2023)

Impaired coupling of local and global functional feedbacks underlies abnormal synchronization and negative symptoms of schizophrenia
por: Noh, Kyungchul, et al.
Publicado: (2013)

Research in China on the molecular genetics of schizophrenia
por: Cui, Donghong, et al.
Publicado: (2012)

Schizophrenia: The Divided Mind
por: Wing, J. K.
Publicado: (1969)

Neurodevelopmental and environmental hypotheses of negative symptoms of schizophrenia
por: Limosin, Frédéric
Publicado: (2014)

A Bioecosystem Theory of Negative Symptoms in Schizophrenia
por: Strauss, Gregory P.
Publicado: (2021)

EPA guidance on treatment of negative symptoms in schizophrenia
por: Galderisi, S., et al.
Publicado: (2021)

EPA guidance on assessment of negative symptoms in schizophrenia
por: Galderisi, S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0fel81feh5i5s5nf7irgarl1ei